EDESA BIOTECH, INC. Marketable Securities (Current)
EDESA BIOTECH, INC. (EDSA) had Marketable Securities (Current) of $0 as of 2016-09-30, per its 10-K filed 2016-12-14.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2016-12-14
- 2016-09-30: Marketable Securities, Current $0.00.
- 2015-09-30: Marketable Securities, Current $5.02M.
- 2014-09-30: Marketable Securities, Current $5.00M.
- 2014-08-31: Marketable Securities, Current $5.00M.
| Period end | Marketable Securities, Current |
|---|---|
| 2016-09-30 | $0.00 10-K · filed 2016-12-14 |
| 2015-09-30 | $5.02M 10-K · filed 2016-12-14 |
| 2014-09-30 | $5.00M 10-K · filed 2015-12-14 |
| 2014-08-31 | $5.00M 10-K · filed 2015-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |